Tag Archives: Investment

BIO Deputy General Counsel Testifies on Patent Reform

patent

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front of the U.S. Senate Judiciary Committee regarding proposed reforms to the current U.S. patent system. The hearing was a chance for the Judiciary committee to listen to experts on what should be done to halt misuse of the patent system. In his remarks, Mr. Sauer noted that while BIO appreciates efforts by Congress to curb patent troll abuses, some of Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , ,

Biotech Stocks: Perspective in a Bull Market

biotech companies

Investors are increasingly interested in biotechnology based on scientific breakthroughs, an improved regulatory environment, strong earnings growth from large companies, and a more mature industry. Recent advancements in biotechnology are revolutionizing treatments and cures for many illnesses, creating new value for the healthcare system. In 2013, our understanding of how therapeutics can be used to harness the immune system to destroy cancer cells exploded with many companies reporting solid data in human testing. In 2014, Read More >

Inside BIO Industry Analysis  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

BIO Announces Cleantech Investor Speakers for 2014 World Congress

World Congress

Emerging companies to showcase their ground-breaking achievements  A selective group of CEOs and COOs from emerging industrial biotechnology companies will present new technologies, accomplishments, and business cases during the Clean Tech Investor Sessions at the BIO World Congress on Industrial Biotechnology, the Biotechnology Industry Organization (BIO) announced today. “The Clean Tech Investor Sessions at BIO’s World Congress on Industrial Biotechnology will help facilitate these much need investment opportunities for emerging companies while granting investors a first-hand look into some of Read More >

Environmental & Industrial, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Buy Side Investors Bullish Ahead of 2014 BIO CEO & Investor Conference

CEO2014_blog copy

2013 was a record year for the biotech sector, with the NASDAQ Biotechnology Index hitting record highs again and again, ending the year up over 60% — beating the S&P 500 more than two-fold.   But what can we expect for 2014? That will be the topic of discussion at our opening plenary panel at next week’s BIO CEO & Investor Conference, taking place Monday and Tuesday, February 10-11 in New York. To help spur Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Dave Thomas

Is 2014 a good time to invest in biotech? How many biotech IPOs will there be? Which sectors will perform the best? To find out what investors think about these questions and more, BIO is conducting its annual Buy-side Investor Perception Survey and releasing the results at the 16th Annual BIO CEO & Investor Conference in New York, Monday Feb. 10. But as the results are coming in, BIO is hosting the #BIOBuyside Twitter chat Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , ,